There is increasing evidence that the renin–angiotensin–aldosterone system (RAAS) is dysregulated in critical illness [5–9], and may represent a modifiable target for treatment of patients with septic shock and AKI [6, 9, 10]. This evidence concerns the gene REN and acute kidney injury.